HMG-CoA Reductase Inhibitors Reduce Adhesion of Human Monocytes to Endothelial Cells
- 14 December 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (4) , 838-844
- https://doi.org/10.1006/bbrc.2001.6066
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- New insights into the pharmacodynamic and pharmacokinetic properties of statinsPublished by Elsevier ,1999
- Low-density lipoprotein-independent effects of statinsCurrent Opinion in Lipidology, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Methods and Endpoint Issues in Clinical Development of Lipid-Acting Agents with Pleiotropic EffectsThe American Journal of Cardiology, 1998
- HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With HypercholesterolemiaJournal of the American College of Cardiology, 1997
- Activation status and function of the VLA-4 (α4β1) integrin expressed on human melanoma cell linesInternational Journal of Cancer, 1997
- Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell lineInternational Journal of Immunopharmacology, 1996
- Statins do more than just lower cholesterolThe Lancet, 1996
- Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cellsBiochemical Pharmacology, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993